| advertise add site services publishers database health videos | ![]() | about toolbar stats live show health store more stuff JOIN/LOGIN |
Group B Streptococcus memorialhealth.com | Streptococcus suis News and Headlines by Microbes.info microbes.info | streptococcus roadback.org |
Streptococcus agalactiae (also known as Group B streptococcus or GBS) is a beta-hemolytic gram-positive streptococcus.
[edit] IdentificationCAMP test is an important test for its identification. Mainly GBS are screened through this test. It is characterized by the presence of group B Lancefield antigen and by its ability to hydrolyze sodium hippurate.[1] It is also sensitive to bile and will lyse in its presence. S. agalactiae's polysaccharide antiphagocytic capsule is its main virulence factor. [edit] Clinical significanceS. agalactiae is a species of the normal flora of the female urogenital tract and rectum. Its chief clinical importance is that it can be transferred to a neonate passing through the birth canal and can cause serious group B streptococcal infection. In the western world, S. agalactiae is the major cause of bacterial septicemia of the newborn, which can lead to death or long-term sequelae. S. agalactiae can also cause neonatal meningitis, which does not present with the hallmark sign of adult meningitis, a stiff neck; rather, it presents with nonspecific symptoms such as fever, vomiting and irritability and can consequently go undiagnosed until it is too late. Hearing loss can be a long-term sequelae of GBS-meningitis. Somewhat more rarely, S. agalactiae can also cause invasive group B streptococcal disease of the adult in the pregnant, elderly, or immunosuppressed. S. agalactiae is present in up to one-third of women of childbearing age, and one in every thousand live births will be affected by group B streptococcal infection. In the elderly or persons with compromised immune systems septicemia or other serious infections are seen. This occurs also rarely during pregnancy or maternity. [edit] PreventionThere is no reliable way to prevent the disease currently, however prophylactic treatment with antibiotics (typically intravenous penicillin) during delivery is the prevention measure most commonly used. Vaccination of adolescent women is considered an ideal solution; however, though research for the development of such a vaccine is underway, a good candidate vaccine has yet to surface. Different western countries use different strategies to select which women in labor are most likely to need antibiotics.
[edit] References
[edit] External links
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ↑ top of page ↑ | about thumbshots |